Friday, 27 April 2018
NIHR Signal Adding the extra antibiotic rifampicin did not improve cure rates after sepsis
NIHR Signal Adding the extra antibiotic rifampicin did not improve cure rates after sepsis
Published on 17 April 2018
Adding the antibiotic rifampicin did not improve cure rates or reduce deaths for people with bacterial blood infections caused by Staphylococcus aureus.
https://discover.dc.nihr.ac.uk/content/signal-00584/adding-the-extra-antibiotic-rifampicin-did-not-improve-cure-rates-after-sepsis
From the NIHR Dessemination Centre
Brain Imaging Can Detect Early-Stage Psychosis
A new study shows that brain imaging techniques can detect the development of psychosis in high-risk patients at an early stage. Researchers from the University of Basel in Switzerland and Western University in Canada stated that detecting psychosis early increases the chances of effective treatment. Click here to read PsychCentral article
Signal Lorazepam confirmed as first-line treatment for stopping prolonged seizures in children
NIHR Signal Lorazepam confirmed as first-line treatment for stopping prolonged seizures in children
Published on 17 April 2018
Intravenous lorazepam is as effective as intravenous diazepam for stopping children’s tonic-clonic seizures in hospital. https://discover.dc.nihr.ac.uk/content/signal-00586/lorazepam-confirmed-as-first-line-treatment-for-stopping-prolonged-seizures-in-children
From the NIHR Dissemination Centre
NIHR Signal Physiotherapy education before major abdominal surgery reduces lung complications
NIHR Signal Physiotherapy education before major abdominal surgery reduces lung complications
Published on 3 April 2018
A physiotherapy session before planned abdominal surgery, explaining the importance of breathing exercises and sitting out of bed as soon after surgery as possible, halves the risk of pneumonia.
https://discover.dc.nihr.ac.uk/content/signal-00579/physiotherapy-before-abdominal-surgery-helps-prevent-pneumonia
From the NIHR Dissemination Centre
Labels:
evidence,
NICE,
patient_outcomes,
physiotherapy,
prevention,
surgery,
xCom,
xMH
New NICE Technology appraisal guidance [TA519] Pembrolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapy
New NICE Technology appraisal guidance [TA519] Pembrolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapy
Published date:
Evidence-based recommendations on pembrolizumab (Keytruda) for previously treated locally advanced or metastatic urothelial carcinoma in adults.
For full guidance https://www.nice.org.uk/guidance/ta519
New NICE Interventional procedures guidance [IPG612] Microinvasive subconjunctival insertion of a trans-scleral gelatin stent for primary open-angle glaucoma
New NICE Interventional procedures guidance [IPG612] Microinvasive subconjunctival insertion of a trans-scleral gelatin stent for primary open-angle glaucoma
Published date:
Published date:
New NICE Interventional procedures guidance [IPG611] Prostate artery embolisation for lower urinary tract symptoms caused by benign prostatic hyperplasia
Interventional procedures guidance [IPG611] Prostate artery embolisation for lower urinary tract symptoms caused by benign prostatic hyperplasia
Published date:
Evidence-based recommendations on prostate artery embolisation for lower urinary tract symptoms caused by benign prostatic hyperplasia in adults. This involves blocking the blood vessels supplying the prostate with tiny plastic particles.
for full guidance https://www.nice.org.uk/guidance/ipg611
Published date:
Evidence-based recommendations on prostate artery embolisation for lower urinary tract symptoms caused by benign prostatic hyperplasia in adults. This involves blocking the blood vessels supplying the prostate with tiny plastic particles.
for full guidance https://www.nice.org.uk/guidance/ipg611
New NICE Interventional procedures guidance [IPG610] Nerve transfer to partially restore upper limb function in tetraplegia
New NICE Interventional procedures guidance [IPG610] Nerve transfer to partially restore upper limb function in tetraplegia
Published date:
Evidence-based recommendations on nerve transfer to partially restore upper limb function in people with tetraplegia. This involves connecting an undamaged, functioning, but non-essential nerve near the injury to the damaged essential nerve.
For full guidance https://www.nice.org.uk/guidance/ipg610
Published date:
Evidence-based recommendations on nerve transfer to partially restore upper limb function in people with tetraplegia. This involves connecting an undamaged, functioning, but non-essential nerve near the injury to the damaged essential nerve.
For full guidance https://www.nice.org.uk/guidance/ipg610
New NICE Interventional procedures guidance [IPG609] Robot-assisted kidney transplant
New NICE Interventional procedures guidance [IPG609] Robot-assisted kidney transplant
Published date:
Evidence-based recommendations on robot-assisted kidney transplant in adults. This involves the surgeon using a robot to help with a kidney transplant.
Read full guidance at https://www.nice.org.uk/guidance/ipg609
Published date:
Evidence-based recommendations on robot-assisted kidney transplant in adults. This involves the surgeon using a robot to help with a kidney transplant.
Read full guidance at https://www.nice.org.uk/guidance/ipg609
Labels:
guidance,
medical_technology,
NICE,
renal,
transplantation,
xCom,
xMH
New NICE Diagnostics guidance DG32 Adjunctive colposcopy technologies for assessing suspected cervical abnormalities
NICE Diagnostics guidance [DG32] Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: the DYSIS colposcope with DYSISmap and the ZedScan I.
Published date:
This guidance replaces the NICE diagnostics guidance on adjunctive colposcopy technologies for examination of the uterine cervix – DySIS and the Niris Imaging System (DG4) and the NICE medtech innovation briefing on ZedScan as an adjunct to colposcopy in women with suspected cervical intra‑epithelial neoplasia (MIB20).
Read full guidance at: https://www.nice.org.uk/guidance/dg32
Published date:
This guidance replaces the NICE diagnostics guidance on adjunctive colposcopy technologies for examination of the uterine cervix – DySIS and the Niris Imaging System (DG4) and the NICE medtech innovation briefing on ZedScan as an adjunct to colposcopy in women with suspected cervical intra‑epithelial neoplasia (MIB20).
Read full guidance at: https://www.nice.org.uk/guidance/dg32
Labels:
cancer,
colposcopy,
diagnosis,
diagnostic_tests,
guidance,
gynaecology,
NICE,
pathology,
xCom,
xMH
Thursday, 26 April 2018
'Breathing space' victory for those struggling with debt while in hospital for their mental health
Thousands of people who are in mental health crisis and struggling with serious debt will be given breathing space from further interest, charges and enforcement action following a campaign victory by the Money and Mental Health Policy Institute. Read MoneySavingExpert article here
When do problems with memory and decision-making affect older adults' ability to drive?
Recently, a team of researchers designed a study to learn more about cognitive health and older drivers' crash risks. The study focused on links between levels of cognitive function and crash risk among older drivers without dementia over a 14-year study period. They also assessed the link between changes in cognitive function over time and later risks of crashes. Read ScienceDaily article here
Wednesday, 25 April 2018
How to Counter Rudeness at Work For A Good Night’s Sleep
If you’ve had a bad day at work thanks to rude colleagues, doing something fun and relaxing afterwards could promote a better night’s sleep. Read PsychCentral article here
Nursing In The Digital Age: Using Technology To Support Patients In The Home
This report is based on a survey of over 500 nurses working in the community. It seeks to determine how far new healthcare information technology has changed and how skills and attitudes within community services have adapted. Read Kings Fund blog here
New NMC figures continue to highlight ‘major concern’ as more EU nurses leave the UK
Today we have released new figures from our register which show a significant rise in the number of EU nurses and midwives leaving the register. Read NMC webpage here
Tuesday, 24 April 2018
Many New Dementia Patients Get Unnecessary Drugs
A new international study finds that medication use in newly diagnosed dementia patients increases by approximately 11 percent within the first year, and a good portion of these drugs are unnecessary or inappropriate. This includes sleeping tablets, pain relievers, depression medications and acid reflux drugs. Click here for PsychCentral article
Cyberbullying Victims May Be Twice as Likely to Self-Harm and Show Suicidal Behaviors
Children and young people under 25 who are victims of cyberbullying are more than twice as likely to self-harm and exhibit suicidal behavior, according to a new U.K. study. But new research also suggests that it is not just the victims of cyberbullying that are more vulnerable to suicidal behaviors. Bullies also are at higher risk of experiencing suicidal thoughts and behaviors. Click here for PsychCentral article
Even a single mindfulness meditation session can reduce anxiety
Mindfulness meditation programs have shown promise for the treatment of anxiety, one of the most common mental health disorders in the US. New research suggests people can begin to derive psychological and physiological benefits from the practice after a single introductory session. Read ScienceDaily article here
Friday, 20 April 2018
Safe and reliable mental health advice for older people and those who care for them
MindEd for Families has launched MindEd for Older People which is a free web-based resource providing information about mental health issues for older people and their families. The resource is supported by NHS England in partnership with Health Education England. Click here for link
Thursday, 19 April 2018
Maternal Depression May Impact Child’s IQ
Maternal depression can negatively impact a child’s cognitive development at least until the age of 16, according to a new study published in the journal Child Development.
Researchers from the University of California (UC), San Diego School of Medicine evaluated approximately 900 healthy children and their mothers living in Santiago, Chile at five-year intervals from the child’s infancy through age 16. Click here to see PsychCentral article
Researchers from the University of California (UC), San Diego School of Medicine evaluated approximately 900 healthy children and their mothers living in Santiago, Chile at five-year intervals from the child’s infancy through age 16. Click here to see PsychCentral article
Cyber Attack On The NHS
The Public Accounts Committee states that the WannaCry cyber-attack on Friday 12 May 2017, was a wake-up call for the NHS. The Department of Health and Social Care and its arm's-length bodies were unprepared for the relatively unsophisticated WannaCry attack; they had not shared and tested plans for responding to a cyber-attack, nor had any trust passed a cyber-security inspection.The report sets an end of June deadline for the Department of Health and Social Care to provide anupdate on costed plans for vital security investment. See Kings Fund blog here
Wednesday, 18 April 2018
NIMH to Host Twitter Chat on Teen Depression
In recognition of Children's Mental Health Awareness Week, the National Institute of Mental Health (NIMH) is hosting a Twitter chat to discuss teen depression. The chat will take place Thursday, May 3, 2018, from 3:00 p.m. to 4:00 p.m. ET. Click here for link
Pembrolizumab for Advanced Hepatocellular Carcinoma – second line onwards
Hepatocellular Carcinoma (HCC) is the most common type of liver cancer. This type of cancer develops from the main liver cells, called hepatocytes. Treatment and survival depends on the stage at which the cancer is diagnosed. HCC is more common in people who have long‐term damage to the liver (cirrhosis) due to a viral infection or excessive alcohol intake.
http://www.io.nihr.ac.uk/report/pembrolizumab-for-advanced-hepatocellular-carcinoma-second-line-onwards/
From the NIHR Innovation Centre
Labels:
cancer,
evidence,
hepatology,
medical_technology,
medicines,
NICE,
xCom,
xMH
Lenabasum for Diffuse Cutaneous Systemic Sclerosis
Systemic Sclerosis (SS) is a rare disease caused by the immune system attacking the tissue which lines underneath the skin and internal organs (connective tissue). The exact cause of SS is not known but it is thought to happen when immune cells attack the body’s own tissues leading to the cells in the connective tissue producing too much collagen which causes scaring and thickening of the tissue. There are 2 types of SS; limited cutaneous SS (a milder form of SS affecting only parts of the body) and diffuse cutaneous SS (a more severe form of SS which can affect the whole body). The main symptoms of diffuse cutaneous SS are hardening of the skin, acid reflux, vomiting and diarrhoea, muscular pain, weakness and cramps. The outlook for people with diffuse cutaneous SS is generally poor due to high risk of life threatening complications such as heart, lung and kidney problems.
http://www.io.nihr.ac.uk/report/lenabasum-for-diffuse-cutaneous-systemic-sclerosis/
from the NIHR Innovation Centre
http://www.io.nihr.ac.uk/report/lenabasum-for-diffuse-cutaneous-systemic-sclerosis/
from the NIHR Innovation Centre
Enasidenib for Relapsed or Refractory Acute Myeloid Leukaemia (AML) with an Isocitrate Dehydrogenase 2 (IDH2) Mutation
Acute myeloid leukaemia (AML) is a type of cancer that causes the bone marrow to produce lots of immature white blood cells. It is most common in people aged 60 years and over. Symptoms of AML may include weakness, fatigue, shortness of breath, recurrent infections, prolonged bleeding, loss in appetite and unintended weight loss. Most patients with AML are treated with standard
chemotherapy.
http://www.io.nihr.ac.uk/report/enasidenib-for-relapsed-or-refractory-acute-myeloid-leukaemia-aml-with-an-isocitrate-dehydrogenase-2-idh2-mutation/
From the NIHR Innovation centre
chemotherapy.
http://www.io.nihr.ac.uk/report/enasidenib-for-relapsed-or-refractory-acute-myeloid-leukaemia-aml-with-an-isocitrate-dehydrogenase-2-idh2-mutation/
From the NIHR Innovation centre
Rigerimod plus Standard of Care for Systemic Lupus Erythematosus
Systemic lupus erythematosus (SLE) is a long-term condition causing inflammation to the joints, skin and other organs. Symptoms presented are usually very general, including fever, joint pain and skin rash but can progress to the most severe, e.g. kidney failure. SLE typically has patterns of flare-ups where the condition gets worse for a period of time. The disease is likely to be caused by a combination of genetic and lifestyle factors and most commonly affects middle-aged women and those of African-Caribbean ethnicity.
http://www.io.nihr.ac.uk/report/rigerimod-plus-standard-of-care-for-systemic-lupus-erythematosus/
From the NIHR Innovation Centre
http://www.io.nihr.ac.uk/report/rigerimod-plus-standard-of-care-for-systemic-lupus-erythematosus/
From the NIHR Innovation Centre
Axitinib for Patients at High Risk of Recurrence of Renal Cell Carcinoma – Adjuvant
Renal cell carcinoma (RCC) is the most common type of kidney cancer. RCC affects the lining of tiny tubes within the kidney which filter waste from the blood, making urine. Symptoms include blood in urine, feeling of lump or mass in the kidney area, weight loss, raised temperature and sweating, back pain on one side (below the ribs), tiredness, loss of appetite and a general feeling of poor health. The main treatment for RCC is surgery to remove the cancer by partly or totally removing the kidney
http://www.io.nihr.ac.uk/report/axitinib-for-patients-at-high-risk-of-recurrence-of-renal-cell-carcinoma-adjuvant/
From the NIHR Innovation Centre
http://www.io.nihr.ac.uk/report/axitinib-for-patients-at-high-risk-of-recurrence-of-renal-cell-carcinoma-adjuvant/
From the NIHR Innovation Centre
How commissioners use research evidence
Researchers want their work to be used and useful, but may not always understand the context in which decisions are made. Most health and care organisations aim to base decisions on the best available evidence, but accessing and interpreting the right evidence at the right time is hard. Researchers need to do what they can to make their research as useful as possible to those making decisions under pressure
https://www.dc.nihr.ac.uk/highlights/health-commissioners-research-evidence/
From the NIHR dissemination Centre
https://www.dc.nihr.ac.uk/highlights/health-commissioners-research-evidence/
From the NIHR dissemination Centre
NIHR Signal Hospital admission rates and costs increase in line with BMI
Each 2kg/m2 rise in body mass index (BMI) above the normal-weight threshold in women aged 55-79 leads to a 5% rise in annual hospital admissions and 7% rise in healthcare costs. In England, £662 million of the annual hospital admission costs in 2013 could be attributed to overweight or obesity in women of this age group.
https://discover.dc.nihr.ac.uk/content/signal-00575/hospital-admission-rates-and-costs-increase-in-line-with-bmi
From the NIHR Dissemination Centre
https://discover.dc.nihr.ac.uk/content/signal-00575/hospital-admission-rates-and-costs-increase-in-line-with-bmi
From the NIHR Dissemination Centre
Tocilizumab for treating giant cell arteritis [TA 518]
New: Technology appraisal guidance
Tocilizumab for treating giant cell arteritis
Evidence-based recommendations on tocilizumab (RoActemra) for treating giant cell arteritis in adults.
https://www.nice.org.uk/guidance/ta518
Tocilizumab for treating giant cell arteritis
Evidence-based recommendations on tocilizumab (RoActemra) for treating giant cell arteritis in adults.
https://www.nice.org.uk/guidance/ta518
Avelumab for treating metastatic Merkel cell carcinoma [TA 517]
New: Technology appraisal guidance
Evidence-based recommendations on avelumab (Bavencio) for treating metastatic (secondary) Merkel cell carcinoma in adults.
https://www.nice.org.uk/guidance/ta517
Evidence-based recommendations on avelumab (Bavencio) for treating metastatic (secondary) Merkel cell carcinoma in adults.
https://www.nice.org.uk/guidance/ta517
Lyme disease [NG95]
New: Guidance
This guideline covers diagnosing and managing Lyme disease. It aims to raise awareness of when Lyme disease should be suspected and ensure that people have prompt and consistent diagnosis and treatment. It does not cover preventing Lyme disease.
https://www.nice.org.uk/guidance/ng95
This guideline covers diagnosing and managing Lyme disease. It aims to raise awareness of when Lyme disease should be suspected and ensure that people have prompt and consistent diagnosis and treatment. It does not cover preventing Lyme disease.
https://www.nice.org.uk/guidance/ng95
Emergency and acute medical care in over 16s: service delivery and organisation [NG94]
New: Guidance
This guideline covers organising and delivering emergency and acute medical care for people aged over 16 in the community and in hospital. It aims to reduce the need for hospital admissions by giving advanced training to paramedics and providing community alternatives to hospital care. It also promotes good-quality care in hospital and joint working between health and social services.
https://www.nice.org.uk/guidance/ng94
This guideline covers organising and delivering emergency and acute medical care for people aged over 16 in the community and in hospital. It aims to reduce the need for hospital admissions by giving advanced training to paramedics and providing community alternatives to hospital care. It also promotes good-quality care in hospital and joint working between health and social services.
https://www.nice.org.uk/guidance/ng94
Monday, 16 April 2018
Depression study pinpoints genes that may trigger the condition
Nearly 80 genes that could be linked to depression have been discovered by scientists.The findings could help explain why some people may be at a higher risk of developing the condition, researchers say.The study could also help researchers develop drugs to tackle mental ill-health, experts say. Click here to read ScienceDaily article
Friday, 13 April 2018
Public Health England. A Review of New Psychoactive Substances in Secure Mental Health Settings
New Psychoactive Substances (NPS) are a group of drugs that are designed to replicate the effects of other illegal substances. Click here to read further.
NHS England. Health and justice mental health services: Safer use of mental health medicines
This document provides a background to prescribing and mental health
medicines in secure environments with some common principles that apply
throughout the medicines optimisation pathway, and more detailed
information within the pathway to support safer practice. Click here to read further.
Mental health of adults in contact with the criminal justice system
This quality standard covers recognising, assessing and managing mental
health problems in adults (aged 18 and over) who are in contact with the
criminal justice system (this includes police contact, court and prison
custody, street triage, liaison and diversion services, and probation
services). It describes high-quality care in priority areas for
improvement. Click here to read further.
Thursday, 12 April 2018
Not Letting Go of Stress Can Impact Health a Decade Later
New research discovers it is important to learn how to keep stress from lingering and carrying over to the next day. Investigators found that people who allow their negative emotional responses to stress to persist into the following day have an increased risk of health problems and physical limitations later in life. Click here to see PsychCentral article
Sexual safety on mental health wards
Deputy Chief Inspector of Hospitals, lead for mental health, Dr Paul Lelliott has written to specialist mental health NHS trusts in England to inform them of an upcoming workshop to explore what can be done to improve sexual safety on mental health wards and thank trusts for engaging with CQC on this work. Click here to see CQC website
Wednesday, 11 April 2018
Valued care in mental health: Improving for excellence
This document presents a national model for improving mental health services. It draws on the diverse experiences of eight mental health providers and includes challenges and learning as well as successful innovations and improvements. Click here for link
Monday, 9 April 2018
Is placebo response in antidepressant trials rising or not? A reanalysis of datasets to conclude this long-lasting controversy
It had long been believed that placebo response rates in antidepressant
trials have been increasing and that they were responsible for rising
numbers of so-called failed antidepressant trials. Two recent systematic
reviews examined this issue and reached completely opposite findings. Click here to read further.
Study IDs Psychosocial Barriers to Treating Childhood Obesity
A new study shows that obese children whose families have elevated
psychological and social risks, including child behavior problems,
parent mental health issues, and family financial difficulties, are more
likely to drop out of weight management treatment and less likely to
lose weight. Click here to read further.
High Levels of Vitamin D Protein Linked to Bipolar Illness in Kids
Researchers at The Ohio State University found that children with bipolar disorder had higher blood levels of a protein associated with Vitamin D compared to children without mood disorders. Click here to read further.
London racing ahead in treating eating disorders in children quickly
The proportion of children with an eating
disorder starting urgent treatment within one
week remains far higher in London than the rest of the
country, according to data analysed by the Royal College of
Psychiatrists. Click here to read further.
Friday, 6 April 2018
Attention deficit disorders could stem from impaired brain coordination
Researchers have discovered how two brain regions work together to
maintain attention, and how discordance between the regions could lead
to attention deficit disorders, including schizophrenia, bipolar
disorder, and major depression. Click here for further details.
Users' experiences of an online intervention for bipolar disorder: important lessons for design and evaluation
The evidence base for digital interventions for physical and mental
health, including severe and enduring mental health difficulties, is
increasing. In a feasibility trial, web-based Enhanced Relapse
Prevention (ERPonline) for bipolar disorder demonstrated high
recruitment and retention rates. Click here to read further.
Thursday, 5 April 2018
Drug misuse prevention
National Institute for Health and Care Excellence (NICE) - This quality standard covers the prevention or delay of harmful use of drugs by children, young people and adults most likely to start using drugs, or already experimenting or using drugs occasionally. Click here to read further.
Think Autism strategy: governance refresh
The way that the Department of Health and Social Care and other
organisations monitor the progress of the autism strategy has been
updated. Click here to read further.
Prescribing antipsychotic medication for children with autism
A new study has suggested that children with intellectual difficulty or
autism are more likely to be given antipsychotic medication from a
younger age than those without intellectual disability and have higher
rates of hospitalisation for depression and for injury and also are at
risk of other medical side effects. Click here to read further.
NHS bodies told to boost mental health funds or face sanctions - The Guardian
NHS bodies that put too little money into improving mental health care have been threatened with sanctions in a crackdown intended to ensure more cash reaches the frontline. Click here to read further.
Wednesday, 4 April 2018
NHS England to transform mental health care for military veterans across the country
Hundreds of military veterans are set to benefit from a nationwide scheme to tackle the most complex mental health needs of ex-armed forces personnel, launched today (Sunday 1 April) by NHS England. Click here to read further.
Tuesday, 3 April 2018
Using chosen names reduces odds of depression and suicide in transgender youths
In one of the largest and most diverse studies of transgender youths to
date, researchers have found that when transgender youths are allowed to
use their chosen name in places such as work, school and at home, their
risk of depression and suicide drops. Click here further details.
Self-rating mental health as 'good' predicts positive future mental health
Researchers have found that when a person rates their current mental
health as 'positive' despite meeting criteria for a mental health
problem such as depression, it can predict good mental health in the
future, even without treatment. Click here to read further.
Centre for Mental Health to investigate inequalities in mental health
Centre for Mental Health today launched an 18-month Commission to investigate inequalities in mental health and make recommendations to reduce them. The Commission for Equality in Mental Health will explore some of the biggest inequalities in mental health in the UK and seek workable, long-term solutions to reduce and if possible eradicate them. Click here to read further.
Investing in better mental health support vital to NHS achieving ‘tough task’ keeping pace with demand for care
The NHS must continue to invest in effective mental health services across the country if it is to meet the challenge set out today by NHS Providers in its report, The Performance Challenge, Centre for Mental Health chief executive Sarah Hughes said today. Click here to read further.
Subscribe to:
Posts (Atom)